Organon & Co | OGN - Zahlungsmittel Und Äquivalente

Aktienkurs
6.12
Täglich Wechseln
0.07 1.16%
Monatlich
-6.28%
Jährlich
-47.13%
Q2 Prognose
6.17




Zahlungsmittel Und Äquivalente Veränderung Datum
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Celltrion KRW 29.65B 799.42B 2025-06
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 51.09M 4.9M 2025-12
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Gilead Sciences USD 7.33B 2.19B 2025-09
Glaxosmithkline GBP 3.3B 303M 2025-09
Kangmei Pharma CNY 1.18B 278M 2025-09
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Merck USD 18.17B 10.16B 2025-09
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Novartis USD 9.56B 2.9B 2025-09
Organigram Holdings CAD 7.58M 20.62M 2025-12
Organon & Co USD 672M 73M 2025-09
Pharma Mar EUR 17.82M 3.78M 2025-12
Qiagen NV USD 1.36B 621.78M 2025-09
Sartorius EUR 389.9M 429.1M 2025-09
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tilray USD 264.83M 43.16M 2025-06
Zealand Pharma A/S 4.58B 1.4B 2025-12